United Capital Financial Advisors LLC Makes New $722,000 Investment in Nutex Health Inc. $NUTX

United Capital Financial Advisors LLC purchased a new position in shares of Nutex Health Inc. (NASDAQ:NUTX) during the second quarter, HoldingsChannel reports. The fund purchased 4,224 shares of the company’s stock, valued at approximately $722,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Kilter Group LLC acquired a new stake in Nutex Health during the 2nd quarter worth $27,000. Allworth Financial LP acquired a new position in Nutex Health in the second quarter valued at about $35,000. Islay Capital Management LLC acquired a new position in Nutex Health in the fourth quarter valued at about $34,000. BNP Paribas Financial Markets increased its holdings in shares of Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on NUTX shares. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Lake Street Capital reissued a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. Finally, Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Nutex Health has an average rating of “Buy” and a consensus target price of $300.00.

Nutex Health Price Performance

NUTX stock opened at $189.25 on Monday. The stock has a 50-day moving average price of $171.62 and a two-hundred day moving average price of $133.84. Nutex Health Inc. has a 1 year low of $77.21 and a 1 year high of $204.00. The stock has a market cap of $1.30 billion, a PE ratio of 7.43 and a beta of 0.24. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. Equities analysts forecast that Nutex Health Inc. will post 30.11 EPS for the current fiscal year.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.